National Breast Cancer Awareness Month 2/3

Search | National Guideline Clearinghouse

• National Breast Cancer Awareness Month (see related guidelines)

• GUIDELINE SUMMARY
 
• NGC:010494
 
• 2014 JULY 1

Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline.

American Society of Clinical Oncology

Compare

• GUIDELINE SUMMARY
 
• NGC:009457
 
• 1997 MAY (REVISED 2013 MAR 1)

Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.

American Society of Clinical Oncology

Compare

• GUIDELINE SUMMARY
 
• NGC:009391
 
• 2012 AUG

Sentinel lymph node biopsy and axillary node dissection in early stage breast cancer.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:010191
 
• 1996 (REVISED 2014 FEB 18)

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

U.S. Preventive Services Task Force

Compare

• GUIDELINE SUMMARY
 
• NGC:010700
 
• 2014 SEP 30

Optimal systemic therapy for early female breast cancer.

Program in Evidence-based Care

Compare

• GUIDELINE SUMMARY
 
• NGC:010957
 
• 2016 APR 1

Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology clinical practice guideline. [Update Pending]

American Society of Clinical Oncology

Compare

• GUIDELINE SUMMARY
 
• NGC:009378
 
• 2012 JUL

Staging investigations for asymptomatic and newly diagnosed breast cancer.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:011064
 
• 2016 JUN 8

Clinical utility of multigene profiling assays in invasive early-stage breast cancer.

Program in Evidence-based Care

Compare

• GUIDELINE SUMMARY
 
• NGC:010558
 
• 2014 OCT 10

Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2–negative (or unknown) advanced breast cancer: American Society of Clinical Oncology clinical practice guideline.

American Society of Clinical Oncology

Compare

• GUIDELINE SUMMARY
 
• NGC:010541
 
• 2013 AUG

Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:009074
 
• 2012 APR

Eribulin for the treatment of locally advanced or metastatic breast cancer.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:011200
 
• 2017 MAR-APR

Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement.

American Society for Radiation Oncology

Compare

• GUIDELINE SUMMARY
 
• NGC:010045
 
• 2007 MAY (REVISED 2013 SEP)

Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.

The North American Menopause Society

Compare

• GUIDELINE SUMMARY
 
• NGC:011028
 
• 2016

ACR Appropriateness Criteria® breast cancer screening.

American College of Radiology

Compare

• GUIDELINE SUMMARY
 
• NGC:009678
 
• 1999 (REVISED 2012)

ACR Appropriateness Criteria® single brain metastasis.

American College of Radiology

Compare

• GUIDELINE SUMMARY
 
• NGC:008960
 
• 1994 JAN (REVISED 2012 JAN)

Diagnosis of breast disease.

Institute for Clinical Systems Improvement

Compare

• GUIDELINE SUMMARY
 
• NGC:009376
 
• 2012 OCT

Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:009658
 
• 1996 SEP (REVISED 2012)

ACR Appropriateness Criteria® palpable breast masses.

American College of Radiology

Compare

• GUIDELINE SUMMARY
 
• NGC:011169
 
• 2017 FEB

Breast reconstruction following prophylactic or therapeutic mastectomy for breast cancer.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:010495
 
• 2014 JULY 1
• Multiple Chronic Conditions
   LEARN MORE ABOUT MULTIPLE CHRONIC CONDITIONS

Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.

American Society of Clinical Oncology